ATE395812T1 - Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests - Google Patents

Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests

Info

Publication number
ATE395812T1
ATE395812T1 AT00935949T AT00935949T ATE395812T1 AT E395812 T1 ATE395812 T1 AT E395812T1 AT 00935949 T AT00935949 T AT 00935949T AT 00935949 T AT00935949 T AT 00935949T AT E395812 T1 ATE395812 T1 AT E395812T1
Authority
AT
Austria
Prior art keywords
hcg
present
sample
test
predicting
Prior art date
Application number
AT00935949T
Other languages
English (en)
Inventor
John O'connor
Steven Birken
Galina Kovalevskaya
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Application granted granted Critical
Publication of ATE395812T1 publication Critical patent/ATE395812T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57545—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57555—Immunoassay; Biospecific binding assay; Materials therefor for cancer of the prostate
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/814—Pregnancy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/815—Test for named compound or class of compounds
    • Y10S436/817—Steroids or hormones
    • Y10S436/818—Human chorionic gonadotropin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Reproductive Health (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT00935949T 1999-05-13 2000-05-12 Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests ATE395812T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/311,428 US6927034B2 (en) 1998-02-03 1999-05-13 Methods for detecting trophoblast malignancy by HCG assay
PCT/US2000/013197 WO2000070094A1 (en) 1999-05-13 2000-05-12 METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY

Publications (1)

Publication Number Publication Date
ATE395812T1 true ATE395812T1 (de) 2006-01-15

Family

ID=23206832

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00935949T ATE395812T1 (de) 1999-05-13 2000-05-12 Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests

Country Status (9)

Country Link
US (8) US6927034B2 (de)
EP (1) EP1183390B8 (de)
AT (1) ATE395812T1 (de)
AU (1) AU778130B2 (de)
CA (1) CA2372666C (de)
DE (1) DE60025347T2 (de)
IL (2) IL146454A0 (de)
NZ (1) NZ516024A (de)
WO (1) WO2000070094A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927034B2 (en) * 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US7198954B1 (en) 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6500627B1 (en) * 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
JP2001349892A (ja) * 2000-04-03 2001-12-21 Unilever Nv 検査方法及びデバイス
WO2003012445A1 (en) 2001-07-30 2003-02-13 Quest Diagnostics Investments Incorporated Methods and kits for detecting ita in a biological sample
US6627457B2 (en) 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
US20030027234A1 (en) * 2001-07-30 2003-02-06 Pandian Murugan R. Methods for detecting Down's syndrome
US7871762B2 (en) * 2002-10-10 2011-01-18 Stc.Unm Hyperglycosylated hCG (invasive trophoblast antigen) in differential diagnosis of malignant or invasive trophoblastic disease
US7572639B2 (en) * 2004-06-03 2009-08-11 Stc.Unm Method and apparatus for predicting pregnancy outcome
US20060105411A1 (en) * 2004-11-15 2006-05-18 Cole Laurence A Method of detecting early pregnancy at high accuracy by measuring hCG and hyperglycosylated hCG concentrations equally
JP2009504659A (ja) * 2005-08-08 2009-02-05 オンコノン・リミテッド・ライアビリティ・カンパニー 抗体組成物、腫瘍性疾患の処置方法、および受胎能の調節方法
WO2007122403A1 (en) * 2006-04-21 2007-11-01 British Pregnancy Advisory Service Device and method for detection of a pregnancy associated hormone
US20080182244A1 (en) * 2006-08-04 2008-07-31 Ikonisys, Inc. Pre-Implantation Genetic Diagnosis Test
WO2009033001A2 (en) * 2007-09-05 2009-03-12 University Of Utah Research Foundation Robust location distinction using teporal link signatures
WO2010030950A2 (en) * 2008-09-12 2010-03-18 University Of Utah Research Foundation Method and system for detecting unauthorized wireless access points using clock skews
US8818288B2 (en) * 2010-07-09 2014-08-26 University Of Utah Research Foundation Statistical inversion method and system for device-free localization in RF sensor networks
CA2802747A1 (en) * 2010-07-13 2012-01-19 Univfy Inc. Method of assessing risk of multiple births in infertility treatments
US10271876B2 (en) 2011-11-23 2019-04-30 Mezadata Medical Ip Holding Llc Method of in vitro fertilization with delay of embryo transfer and use of peripheral blood mononuclear cells
US8999728B2 (en) * 2011-12-21 2015-04-07 Church & Dwight Co., Inc. Diagnostic detection device
US9177098B2 (en) 2012-10-17 2015-11-03 Celmatix Inc. Systems and methods for determining the probability of a pregnancy at a selected point in time
EP3221444B1 (de) * 2014-11-18 2022-03-02 Siemens Healthcare Diagnostics Inc. Lateralflussassayverhältnistest
US20190080800A1 (en) * 2017-04-06 2019-03-14 Celmatix Inc. Methods for assessing the potential for reproductive success and informing treatment therefrom
US10603075B1 (en) 2018-11-30 2020-03-31 Ohana Biosciences, Inc. Compositions and methods for enhancing sperm function
CN119731307A (zh) 2022-08-19 2025-03-28 国家科学和技术研究委员会(Conicet) 用于改善精子功能和受精能力以供辅助生殖技术的方法

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
US4514505A (en) 1982-05-21 1985-04-30 The Trustees Of Columbia University In The City Of New York Monoclonal antibody mixtures and use thereof for enhanced sensitivity immunoassays
EP0345260A4 (de) 1986-12-22 1990-05-14 Univ Queensland Verfahren zur behandlung von säugetieren mit antikörpern gegen den frühempfangnisfaktor (epf).
US5260421A (en) 1987-12-21 1993-11-09 Applied Research Systems Ars Holding N.V. Site-directed mutagenesis modified glycoprotein hormones
JPH06502494A (ja) 1990-10-17 1994-03-17 コール，ローレンス　エイ 癌、妊娠および栄養化細胞病の経過を検出し追従する方法
JPH04300896A (ja) 1991-03-29 1992-10-23 Hiroshi Sueoka ヒト由来の早期妊娠因子及びその分離・精製法
US6339143B1 (en) * 1993-05-13 2002-01-15 The Trustees Of Columbia University In The City Of New York Methods of using antibodies against hormone-related determinants
JP3950481B2 (ja) * 1996-09-06 2007-08-01 エール ユニバーシティ 高グリコシル化ゴナドトロピンを用いるダウン症候群の出生前のスクリーニング
ES2187622T3 (es) 1996-09-27 2003-06-16 Inverness Medical Switzerland Reactivos y dispositivos de ensayo.
US6927034B2 (en) 1998-02-03 2005-08-09 The Trustees Of Columbia University In The City Of New York Methods for detecting trophoblast malignancy by HCG assay
US6500627B1 (en) 1998-02-03 2002-12-31 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by HCG assay
US7198954B1 (en) * 1999-02-03 2007-04-03 The Trustees Of Columbia University In The City Of New York Methods for predicting pregnancy outcome in a subject by hCG assay
US6627457B2 (en) * 2001-07-30 2003-09-30 Quest Diagnostics Investments Incorporated Methods for detecting pregnancy
KR101301979B1 (ko) 2010-12-21 2013-08-30 주식회사 케이티 근거리 통신을 위한 액세스 포인트를 이용한 위치 측정 방법 및 장치와 액세스 포인트의 위치 추정 방법

Also Published As

Publication number Publication date
US8802381B2 (en) 2014-08-12
US20110300557A1 (en) 2011-12-08
US20140087393A1 (en) 2014-03-27
US20050042702A1 (en) 2005-02-24
US8420339B2 (en) 2013-04-16
US20030003597A1 (en) 2003-01-02
DE60025347T2 (de) 2006-09-14
US7285391B2 (en) 2007-10-23
US20080108089A1 (en) 2008-05-08
EP1183390A4 (de) 2003-05-07
US7993858B2 (en) 2011-08-09
AU5133400A (en) 2000-12-05
IL146454A (en) 2007-10-31
US6927034B2 (en) 2005-08-09
EP1183390B1 (de) 2006-01-04
IL146454A0 (en) 2002-07-25
EP1183390B8 (de) 2006-05-03
WO2000070094A1 (en) 2000-11-23
US20130011858A1 (en) 2013-01-10
US20150010926A1 (en) 2015-01-08
EP1183390A1 (de) 2002-03-06
US20110159526A1 (en) 2011-06-30
DE60025347D1 (de) 2006-03-30
US7790403B2 (en) 2010-09-07
NZ516024A (en) 2004-03-26
CA2372666A1 (en) 2000-11-23
CA2372666C (en) 2010-02-09
US8163508B2 (en) 2012-04-24
AU778130B2 (en) 2004-11-18

Similar Documents

Publication Publication Date Title
ATE395812T1 (de) Methoden zur vorhersage eines schwangerschaftsergebnisses bei einer testperson mit hilfe eines hcg-tests
WO1999041584A3 (en) METHODS FOR PREDICTING PREGNANCY OUTCOME IN A SUBJECT BY hCG ASSAY
WO2006126008A3 (en) Improved immunoassay methods
ATE519109T1 (de) Präeklampsie-diagnose
DE60129151D1 (de) Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6)
WO2004089187A3 (en) Caries risk test for predicting and assessing the risk of disease
AU2003288027A1 (en) Scd40l, papp-a and placental growth factor (plgf) used as a biochemical marker combination in cardiovascular diseases
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
DE60232248D1 (de) Schwangerschaftsnachweisverfahren
DE602006021777D1 (de) Diagnoseverfahren für präeklampsie
EP1214447B8 (de) Nachweis des pyruvatkinase-isoenzyms im stuhl
ATE427490T1 (de) Verfahren zur probenvorbehandlung sowie immunologisches testverfahren unter verwendung davon
WO2005071407A3 (en) Methods of diagnosing acute coronary syndrome by measuring urotensin ii
DE69942215D1 (de) Verfahren zum immunochemischen Testen des Anti-HM1.24-Antikörpers
DE60138192D1 (de) Verfahren zur quantifizierung der akt-protein-expression
WO2002077645A3 (en) Method for the measurement of soluble analytes
WO2006004958A3 (en) Detection or measurement of antibodies to antigenic proteins in biological tissues or samples
CY1109461T1 (el) Βελτιωμενες μεθοδοι ανοσολογικου προσδιορισμου
DE60012723D1 (de) Verfahren zur bestimmung von disaccharidasen
ATE412181T1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
CA2358504A1 (en) Methods of determining an increased risk of a woman carrying a downs syndrome affected fetus by measuring an analyte in a biological sample
AU2001225377A1 (en) Lipoprotein assay
BRPI0415562A (pt) reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma
DE60038557D1 (en) Assay

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties